Success Story: NIW Approval for a Computational Biology Researcher Advancing Scalable Genotyping Platforms for Precision Medicine
Client’s Testimonial:
"I highly recommend WeGreen for anyone applying for an EB2-NIW. They are very professional, responsive, and knowledgeable about immigration-related questions. The NIW process is long and filled with a lot of legal forms and paperwork, but WeGreen’s experience made navigating it so much smoother. They guided me step-by-step through complex documents, saving me a huge amount of time and effort throughout the entire application."
On June 12th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a PhD Student in the Field of Computational Biology (Approval Notice).
General Field: Computational Biology
Position at the Time of Case Filing: PhD Student
Country of Origin: Taiwan
State of Residence at the Time of Filing: Maryland
Approval Notice Date: June 12th, 2026
Processing Time: 5 months, 26 days (Premium Processing Upgrade Requested)
Case Summary:
The client’s work sits at the intersection of computational biology and electronics engineering, leveraging data-driven methods to advance modern genomics. Holding an M.S. in electronics engineering, the client has transitioned into computational biology research focused on developing state-of-the-art genotyping platforms for human immune genes. The approved National Interest Waiver (NIW) petition recognizes the importance of this work in enabling scalable and affordable approaches to genetic analysis that support the future of personalized medical care.
Significance of the Proposed Endeavor
We demonstrated that the client’s research addresses a critical national and global need for improved genetic testing infrastructure. By developing computational frameworks for analyzing immune gene variation, the client’s work directly contributes to enhancing personalized medicine, particularly in areas such as immune-related disease detection and treatment optimization.
The proposed endeavor was further shown to have substantial merit and national importance due to its potential to improve healthcare outcomes through more precise genetic profiling. This includes enabling better understanding of immune system variation across populations and supporting more effective clinical decision-making for complex diseases.
Evidence of Professional Achievement and Research Impact
The client’s record of scholarly output and research influence played a central role in establishing eligibility under the NIW framework:
- 3 peer-reviewed journal articles (including 2 first-authored and 1 co-first-authored)
- 6 peer-reviewed conference papers (including 2 first-authored)
- 3 preprints (including 1 co-first-authored)
- Approximately 50 citations to published work
Rather than viewing these metrics in isolation, we demonstrated that they reflect growing recognition of the client’s contributions to computational genomics and immune gene analysis. The citation record, in particular, shows that the client’s methods and findings are being utilized by other researchers working on genomic sequencing, reference bias reduction, and immune repertoire analysis.
Research Funding and External Validation
Additional evidence of the importance and credibility of the client’s work is demonstrated through competitive research funding support from major national scientific agencies, including the National Institute of General Medical Sciences and the National Human Genome Research Institute. This funding underscores the alignment of the client’s research with federally recognized priorities in genomic medicine, computational biology, and precision health technologies.
Recommendation Letter Evidence
A key supporting letter from an expert in the field further validated the client’s technical contributions and research impact. The recommendation emphasized the practical relevance of the client’s computational methods and their influence on ongoing genomic research efforts.
“It is therefore within the interests of the United States to allow [Client’s] research to continue.”
This independent endorsement reinforced the conclusion that the client’s work is not only technically significant but also actively informing and supporting related research in the field.
Outcome and NIW Approval
Based on the totality of evidence, including the client’s advanced training, active research role, publication record, citation impact, funding recognition, and expert validation, we demonstrated that the client is well positioned to continue advancing the proposed endeavor. The work’s clear relevance to scalable genomic technologies and personalized medicine further supported the finding that it holds substantial merit and national importance.
Accordingly, the I-140 National Interest Waiver petition was approved, recognizing the client’s continued potential to contribute to the advancement of computational biology and precision healthcare systems in the United States.